MGMarc C. Goudge

Marc C. Goudge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marc C. Goudge has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Screening of amphipathic helices identifies features linked to inner nuclear membrane properties

    by Shoken Lee, Anabel-Lise Le Roux, Marc Goudge, Mira Mors, Stefano Vanni, Pere Roca‑Cusachs, Shirin Bahmanyar

    Inner nuclear membrane (INM) proteins control numerous nuclear functions, yet properties governing peripheral INM-association remain poorly defined. Here, we perform an image-based screen to identify features in candidate and established amphipathic helices (AHs) that mediate INM association. AHs that localize to ER/Golgi membranes become INM-associated when directed to the nucleus, whereas mitochondrial-localized AHs become largely nucleoplasmic. Mutating a mitochondrial-localized AH to increase its preference for membranes with lipid packing defects enables INM-association upon nuclear targeting. Structural studies of an INM-associated AH in TMEM214 show folding upon binding to lipid packing defects, and full-length TMEM214 localizes to nuclear pores. Consistently across multiple AHs, INM binding depends primarily on sensitivity to lipid packing defects, with a minor electrostatic contribution. Highlighting distinct effects of different mechanical inputs, nuclear swelling, but not cell stretching, enhances INM association of select AHs. These findings define AH features that promote INM association, with implications for nucleo-mechanical responses.


  • Open Access

    Hierarchical membrane-chromatin tethering buffers nuclear envelope assembly against alterations in lipid flux

    by Sarah R. Barger, Sofia Sepùlveda, Han Yang, Marc Goudge, Shoken Lee, Neale D. Ridgway, Shirin Bahmanyar

    In open mitosis, a single nuclear envelope (NE) forms around segregated chromosomes despite an excess of membrane-chromatin tethers. Here, we identify a hierarchical relationship between the BAF binding membrane tethers LEM-2 and Emerin, in which LEM-2 preferentially accumulates at BAF binding sites during postmitotic NE assembly and limits Emerin accumulation in C. elegans embryos. When LEM-2 is absent, Emerin occupies these sites and compensates for LEM-2 loss; however, NE formation becomes sensitized to ER membrane abundance - excessive phospholipid production through loss of CTDNEP1/CNEP-1 causes membrane invasions in interchromosomal regions and, across multiple systems, formation of lobulated, unstable nuclei with abnormal Emerin accumulations. We find that human CTDNEP1 regulates the NE-associated enzyme CCTa; to maintain phosphatidylcholine (PC) homeostasis through preventing delayed PC breakdown. Restoring PC levels rescues Emerin assembly and nuclear morphology defects resulting from the combined loss of CTDNEP1 and LEMD2. Together, these findings link membrane-chromatin tethering to ER lipid content and reveal preferential tethering as a determinant of NE assembly fidelity, with broad relevance to disease-related nuclear defects.


  • Litmus-Body: A Molecularly Targeted Sensor for Cell-Surface pH Measurements

    by Joe Chin-Hun Kuo, Marc C. Goudge, Ann E. Metzloff, Ling-Ting Huang, Marshall J. Colville, Sangwoo Park, Warren R. Zipfel, Matthew J. Paszek

    Precise pH measurements in the immediate environment of receptors is essential for elucidating the mechanisms through which local pH changes associated with diseased phenotypes manifest into aberrant receptor function. However, current pH sensors lack the ability to localize and target specific receptor molecules required to make these measurements. Herein we present the Litmus-body, our recombinant protein-based pH sensor, which through fusion to an IgG nanobody is capable of piggybacking on IgG antibodies for molecular targeting to specific proteins on the cell surface. By normalizing a pH-dependent green fluorescent protein to a long-Stokes shift red fluorophore or fluorescent protein, we readily report pH independent of sensor concentration using a single 488-nm excitation. Our Litmus-body showed excellent responsiveness in solution, with a greater than 50-fold change across the regime of physiological pH. The sensor was further validated for use on live cells and shown to be specific to the protein of interest. In complex with our Litmus-body, Cetuximab therapeutic antibody retained its functionality in binding and inhibiting ligand interaction of its target epidermal growth factor receptor (EGFR), triggering receptor-mediated endocytosis that allowed tracking of local pH from the cell surface through the endocytic pathway.


  • Open Access

    Litmus-Body: a Molecularly Targeted Sensor for Cell-Surface pH Measurements

    by Marc C. Goudge, Joe Chin-Hun Kuo, Ann E. Metzloff, Ling-Ting Huang, Marshall J. Colville, Warren R. Zipfel, Matthew J. Paszek

    Precise pH measurements in the immediate environment of receptors is essential for elucidating the mechanisms through which local pH changes associated with diseased phenotypes manifest into aberrant receptor function. However, current pH sensors lack the molecular specificity required to make these measurements. Herein we present the Litmus-body, our recombinant protein-based pH sensor, which through fusion to an anti-mouse IgG nanobody is capable of molecular targeting to specific proteins on the cell surface. By normalizing a pH-dependent green fluorescent protein to a long-Stokes shift red fluorophore or fluorescent protein, we readily report pH independent of sensor concentration using a single 488-nm excitation. Our Litmus-body showed excellent responsiveness in solution, with a greater than 50-fold change across the physiological regime of pH. The sensor was further validated for use on live cells, shown to be specific to the protein of interest, and was able to successfully recapitulate the numerous pH changes along the endocytic pathway.

  • Mucin‐coating technologies for protection and reduced aggregation of cellular production systems

    by Carolyn R. Shurer, Shelby E. Head, Marc C. Goudge, Matthew J. Paszek

    Optimization of host‐cell production systems with improved yield and production reliability is desired to meet the increasing demand for biologics with complex posttranslational modifications. Aggregation of suspension‐adapted mammalian cells remains a significant problem that can limit the cellular density and per volume yield of bioreactors. Here, we propose a genetically encoded technology that directs the synthesis of antiadhesive and protective coatings on the cellular surface. Inspired by the natural ability of mucin glycoproteins to resist cellular adhesion and hydrate and protect cell and tissue surfaces, we genetically encode new cell‐surface coatings through the fusion of engineered mucin domains to synthetic transmembrane anchors. Combined with appropriate expression systems, the mucin‐coating technology directs the assembly of thick, highly hydrated barriers to strongly mitigate cell aggregation and protect cells in suspension against fluid shear stresses. The coating technology is demonstrated on suspension‐adapted human 293‐F cells, which resist clumping even in media formulations that otherwise would induce extreme cell aggregation and show improved performance over a commercially available anticlumping agent. The stable biopolymer coatings do not show deleterious effects on cell proliferation rate, efficiency of transient transfection with complementary DNAs, or recombinant protein expression. Overall, our mucin‐coating technology and engineered cell lines have the potential to improve the single‐cell growth and viability of suspended cells in bioreactors.